The Role of Immunotherapy in Urologic Cancers.
Journal
Missouri medicine
ISSN: 0026-6620
Titre abrégé: Mo Med
Pays: United States
ID NLM: 0400744
Informations de publication
Date de publication:
Historique:
entrez:
21
4
2020
pubmed:
21
4
2020
medline:
20
11
2020
Statut:
ppublish
Résumé
In recent decades, there has been significant growth in the understanding of the immune system and its role in cancer. The recent introduction of checkpoint inhibitors has drastically changed the treatment landscape of cancer as a whole. In this review, we discuss the major clinical developments of immunotherapy in urologic specific cancers, as well as address future directions in this field.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
127-132Informations de copyright
Copyright 2020 by the Missouri State Medical Association.
Références
N Engl J Med. 2015 Nov 5;373(19):1803-13
pubmed: 26406148
Lancet Oncol. 2017 May;18(5):623-630
pubmed: 28291584
N Engl J Med. 2012 Jun 28;366(26):2443-54
pubmed: 22658127
N Engl J Med. 2019 Mar 21;380(12):1116-1127
pubmed: 30779529
Lancet Oncol. 2017 Feb;18(2):212-220
pubmed: 28081914
Ann Oncol. 2019 Jun 1;30(6):970-976
pubmed: 31050707
N Engl J Med. 2019 Mar 21;380(12):1103-1115
pubmed: 30779531
Lancet Oncol. 2014 Jun;15(7):700-12
pubmed: 24831977
Lancet. 2017 Jan 7;389(10064):67-76
pubmed: 27939400
JAMA Oncol. 2017 Sep 14;3(9):e172411
pubmed: 28817753
Nat Med. 2018 Jun;24(6):749-757
pubmed: 29867230
J Urol. 1976 Aug;116(2):180-3
pubmed: 820877
BJU Int. 2013 Aug;112(3):288-97
pubmed: 23517232
Lancet. 2016 May 7;387(10031):1909-20
pubmed: 26952546
Lancet. 2018 Feb 24;391(10122):748-757
pubmed: 29268948
Lancet. 2009 Mar 28;373(9669):1119-32
pubmed: 19269025
Lancet Oncol. 2017 Mar;18(3):312-322
pubmed: 28131785
Prostate. 2009 Nov 1;69(15):1694-703
pubmed: 19670224
Lancet Oncol. 2018 Jan;19(1):51-64
pubmed: 29217288
J Clin Oncol. 1995 Mar;13(3):688-96
pubmed: 7884429
Lancet Oncol. 2016 Nov;17(11):1590-1598
pubmed: 27733243
Lancet Oncol. 2017 Nov;18(11):1483-1492
pubmed: 28967485
J Clin Oncol. 2017 Jan;35(1):40-47
pubmed: 28034081
Immunotargets Ther. 2017 Mar 20;6:11-16
pubmed: 28361045
Nature. 2014 Nov 27;515(7528):558-62
pubmed: 25428503
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
P T. 2011 Apr;36(4):197-202
pubmed: 21572775